University of California San Diego Researchers Develop Gene Therapy Targeting Brain Cell Mechanisms in Alzheimer’s Disease

Researchers at the University of California San Diego School of Medicine have developed a gene therapy for Alzheimer’s disease that aims to protect the brain from damage and preserve cognitive function. This approach differs from existing treatments, which primarily target unhealthy protein deposits in the brain. Instead, the new therapy focuses on addressing the root cause of Alzheimer’s by influencing how brain cells behave.

The research team designed this innovative treatment to modify cellular activity within the brain, potentially offering a more direct method of combating Alzheimer’s progression. Current therapies often concentrate on removing or reducing abnormal protein accumulations associated with the disease, such as amyloid plaques and tau tangles. However, this gene therapy seeks to intervene at a deeper level by altering brain cell mechanisms that contribute to neurodegeneration. The findings suggest that targeting these underlying processes may provide an alternative pathway for preserving cognitive abilities in individuals affected by Alzheimer’s disease.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 5, 2025

Related posts:

Generic Biopharmaceutical Development: Freedom to Operate Analysis and Stability Testing Crucial for Market Entry Layoffs at Health Agencies Threaten Grant Distribution and Services for Americans with Disabilities. Movement Addresses U.S. Mental Health Crisis, Aims to Improve Access and Promote Early Intervention NIH New Grant Funding Reduced by $2.3 Billion This Year

Author

Mark Chiang